Addus HomeCare (ADUS) to Release Earnings on Monday

Addus HomeCare (NASDAQ:ADUS) is expected to release its Q3 2025 results after the market closes on Monday, November 3rd. Analysts expect Addus HomeCare to post earnings of $1.53 per share and revenue of $354.4780 million for the quarter. Investors are encouraged to explore the company’s upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Tuesday, November 4, 2025 at 9:00 AM ET.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, August 4th. The company reported $1.49 earnings per share for the quarter, topping the consensus estimate of $1.45 by $0.04. The firm had revenue of $349.44 million for the quarter, compared to analysts’ expectations of $345.71 million. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The business’s quarterly revenue was up 21.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.35 EPS. On average, analysts expect Addus HomeCare to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Addus HomeCare Stock Performance

Shares of NASDAQ ADUS opened at $116.89 on Friday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.17. Addus HomeCare has a 12-month low of $88.96 and a 12-month high of $136.72. The firm has a market capitalization of $2.15 billion, a price-to-earnings ratio of 25.80, a price-to-earnings-growth ratio of 1.87 and a beta of 0.86. The firm has a 50 day moving average of $115.28 and a 200 day moving average of $112.04.

Analyst Ratings Changes

ADUS has been the topic of a number of recent research reports. JMP Securities reaffirmed a “market outperform” rating and issued a $150.00 target price on shares of Addus HomeCare in a report on Wednesday, July 16th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, October 8th. Royal Bank Of Canada lifted their price objective on Addus HomeCare from $133.00 to $134.00 and gave the company an “outperform” rating in a research report on Friday, August 22nd. Barclays increased their target price on shares of Addus HomeCare from $83.00 to $109.00 and gave the stock an “underweight” rating in a report on Tuesday, August 19th. Finally, TD Cowen lifted their price target on shares of Addus HomeCare from $135.00 to $139.00 and gave the company a “buy” rating in a report on Wednesday, August 6th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Addus HomeCare currently has a consensus rating of “Moderate Buy” and a consensus target price of $137.50.

Insider Transactions at Addus HomeCare

In related news, EVP Brian Poff sold 7,739 shares of the business’s stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $116.82, for a total value of $904,069.98. Following the sale, the executive vice president directly owned 56,980 shares in the company, valued at approximately $6,656,403.60. The trade was a 11.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO R Dirk Allison sold 25,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $114.95, for a total value of $2,873,750.00. Following the transaction, the chief executive officer owned 166,461 shares of the company’s stock, valued at $19,134,691.95. This represents a 13.06% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 34,310 shares of company stock valued at $3,958,375. 4.50% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Addus HomeCare

Several large investors have recently bought and sold shares of ADUS. Adage Capital Partners GP L.L.C. purchased a new stake in Addus HomeCare during the second quarter valued at $4,838,000. Invesco Ltd. increased its holdings in shares of Addus HomeCare by 5.9% in the 2nd quarter. Invesco Ltd. now owns 439,336 shares of the company’s stock worth $50,607,000 after buying an additional 24,631 shares during the last quarter. Bank of America Corp DE raised its position in shares of Addus HomeCare by 17.4% during the 2nd quarter. Bank of America Corp DE now owns 156,923 shares of the company’s stock valued at $18,076,000 after buying an additional 23,227 shares in the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main lifted its holdings in shares of Addus HomeCare by 194.6% in the 2nd quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 26,030 shares of the company’s stock valued at $2,998,000 after acquiring an additional 17,194 shares during the last quarter. Finally, State Street Corp lifted its holdings in shares of Addus HomeCare by 1.3% in the 2nd quarter. State Street Corp now owns 693,368 shares of the company’s stock valued at $79,869,000 after acquiring an additional 8,925 shares during the last quarter. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.